Skip to main content
SpringerLink
Log in

Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS)

  • Full Papers
  • Published:
Journal of Neural Transmission / General Section JNT Aims and scope Submit manuscript

Summary

Single photon emission tomography (SPET) permits the in vivo measurements of regional cerebral radioactivity in the human brain following the administration of compounds labeled with photon-emitting isotopes. According to our SPET findings of a reduced binding of [123I]labeled (S)-2-hydroxy-3-iodo-6-methoxy-([1-ethyl-2-pyrrolidinyl]methyl) benzamide (IBZM) (a highly selective CNS D2 dopamine receptor ligand) to D2 dopamine receptors in striatal structures in untreated patients with nocturnal myoclonus syndrome (NMS) it seemed to be of interest to investigate whether there are changes in D2 receptor binding under dopamine replacement therapy or not. We studied the uptake and distribution of [123I]IBZM before and in the course of dopamine replacement therapy in four patients with severe insomnia caused by a nocturnal myoclonus syndrome (NMS). We found an increase of the IBZM binding to D2 receptors in the course of treatment, which was associated with an improvement of sleep quality. Reasons for this are discussed. The [123I]IBZM SPET technique in conclusion offers an interesting tool for in vivo investigations of functional changes in the dopaminergic neurotransmitter system in longitudinal studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akpinar S (1982) Treatment of restless legs syndrome with levodopa plus benserazid. Arch Neurol 39: 739

    Google Scholar 

  • Brodeur C, Montplaisir J, Goudbout R, Marinier R (1988) Treatment of restless legs syndrome and periodic movements during sleep with L-dopa. Neurology 38: 1845–1848

    PubMed  Google Scholar 

  • Brücke T, Podreka I, Angelberger P, Wenger S, Topitz A, Kufferle B, Müller C, Deecke L (1991) Dopamine D2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 11: 220–228

    PubMed  Google Scholar 

  • Coleman RM, Pollak CP, Weitzman ED (1980) Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol 8: 416–421

    PubMed  Google Scholar 

  • Dawson VL, Dawson TM, Filloux FM, Wamsley JK (1988) Evidence for dopamine D2 receptors on cholinergic interneurons in the rat caudate-putamen. Life Sci 42: 1933–1939

    PubMed  Google Scholar 

  • Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15: 133–139

    PubMed  Google Scholar 

  • Greenamyre JT (1993) Glutamate-dopamine interaction in the basal ganglia: relationship to Parkinson's disease. J Neural Transm [GenSect] 91: 255–269

    Google Scholar 

  • Guilleminault C, Cetel M, Philip P (1993) Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 43: 445

    PubMed  Google Scholar 

  • Innis RB, Malison RT, Al-Tikriti M, Hoffer PB, Sybirska EH, Seibyl JP, Zoghbi SS, Baldwin RM, Laruelle M, Smith EO, Charney DS, Heninger G, Elsworth JD, Roth RH (1992) Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates. Synapse 10: 177–184

    PubMed  Google Scholar 

  • Kung HF, Kasliwal R, Pan S, Kung M-P, Mach RH, Guo Y-Z (1988) Dopamine D2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling and in vitro binding of R-(+) and S-(−)3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl)-2-pyrrolidinyl) methyl]benzamide (IBZM). J Med Chem 31: 1039–1043

    PubMed  Google Scholar 

  • Maura G, Giardi A, Raiteri M (1988) Release-regulating D2 dopamine receptors are located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther 247: 680–684

    PubMed  Google Scholar 

  • Nordström A-L, Farde L, Wiesel F-A, Forslund K, Pauli S, Halldin C, Uppfeldt G (1993) Central D2 dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33: 227–235

    PubMed  Google Scholar 

  • Reches A, Wagner HR, Jackson-Lewis V, Yablonskaya-Alter E, Fahn S (1984) Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum. Neurology 34: 1208–1212

    PubMed  Google Scholar 

  • Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, Brain Information Service/Brain Research Institute, UCLA

    Google Scholar 

  • Robertson MM (1990) Gilles de la Tourette's syndrome. Eur J Nucl Med 16: 843–845

    PubMed  Google Scholar 

  • Robertson HA (1986) Cerebral decortication reverses the effect of amphetamine on D2 dopamine binding site density. Neurosci Lett 72: 325–329

    PubMed  Google Scholar 

  • Seibyl JP, Woods SW, Zoghbi SS, Baldwin RM, Dey HM, Goddard AW, Zea-Ponce Y, Zubal G, Germine M, Smith EO, Heninger GR, Charney DS, Kung HF, Alavi A, Hoffer PB, Innis RB (1992) Dynamic SPECT imaging of dopamine D2 receptors in human subjects with iodine-123-IBZM. J Nucl Med 33: 1964–1971

    PubMed  Google Scholar 

  • Staedt J, Stoppe G, Kögler A, Munz DL, Riemann H, Emrich D, Rüther E (1993 a) Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm [GenSect] 93: 71–74

    Google Scholar 

  • Staedt J, Windt H, Hajak G, Stoppe G, Rudolph G, Ensink FBM, Hildebrandt J, Rüther E (1993 b) Cluster arousal analysis in chronic pain disturbed sleep. J Sleep Res 2: 134–137

    PubMed  Google Scholar 

  • Staedt J, Stoppe G, Kögler A, Munz DL, Hajak G, Staedt U, Riemann H, Rüther E (1994) Nächtliches Myoklonie-Syndrom (NMS) und Restless Legs Syndrom (RLS). Fortschr Neurol Psychiat 62: 88–93

    PubMed  Google Scholar 

  • Tatsch K, Schwarz J, Oertel WH, Kirsch CM (1991) SPECT imaging of dopamine D2 receptors with [123I]IBZM: Initial experience in controls and patients with Parkinson's syndrome and Wilson's disease. Nucl Med Com 12: 699–707

    Google Scholar 

  • Trendelenburg U (1966) Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 18: 629–640

    PubMed  Google Scholar 

  • Walters AS, Hennig WA, Kavey N, Chokroverty S, Gidro-Frank S (1988) A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24: 455–458

    PubMed  Google Scholar 

  • Zipp F, Baas H, Fischer P-A (1993) Lamotrigine—antiparkinsonian activity by blockade of glutamate release? J Neural Transm [P-D Sect] 5: 67–75

    Google Scholar 

  • Zubal IG, Harrell C, Woods SW, Innis RB, Hoffer PB, Caride VJ, Zimmerman RE (1990) Comparison of quantitation linearity of three brain SPECT imaging instruments using Tc-99m and I-123. J Nucl Med 31: 769–770

    Google Scholar 

Download references

Author information

Author notes

  1. J. Staedt

    Present address: Department of Psychiatry, Georg August University, Göttingen, Federal Republic of Germany

Authors and Affiliations

  1. Department of Psychiatry, Georg August University, Göttingen, Federal Republic of Germany

    G. Stoppe, H. Riemann, G. Hajak & E. Rüther

  2. Department of Nuclear Medicine, Georg August University, Göttingen, Federal Republic of Germany

    A. Kögler & D. Emrich

  3. Department of Nuclear Medicine, Humboldt University (Charité), Berlin, Federal Republic of Germany

    D. L. Munz

Authors
  1. J. Staedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Stoppe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Kögler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Riemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Hajak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. L. Munz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Emrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Rüther
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staedt, J., Stoppe, G., Kögler, A. et al. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J. Neural Transmission 99, 187–193 (1995). https://doi.org/10.1007/BF01271478

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01271478

Keywords

Search

Navigation